Last reviewed · How we verify
RCT of Intralesional Rituximab Injection Versus Involved Site Radiation Therapy in Ocular Adnexal MALT Lymphoma
This project proposes to establish a prospective, multicenter, randomized, controlled clinical study to compare the safety and efficacy of Intralesional Rituximab Injection versus Involved Site Radiation Therapy for the treatment of primary ocular adnexal MALT lymphoma. The aim is to provide high-level clinical evidence for the treatment of ocular adnexal MALT lymphoma and to offer patients treatment options that have fewer complications and comparable therapeutic effects.
Details
| Lead sponsor | Zhongshan Ophthalmic Center, Sun Yat-sen University |
|---|---|
| Phase | NA |
| Status | NOT_YET_RECRUITING |
| Enrolment | 108 |
| Start date | Sat Oct 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Oct 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Primary Ocular Adnexal MALT Lymphoma
Interventions
- Rituximab
- Involved Site Radiation Therapy